Impact of Efavirenz Mid-dose Plasma Concentration on Long-Term Weight Change Among Virologically Suppressed People Living With HIV-Reference-Cited by-同舟云学术

Impact of Efavirenz Mid-dose Plasma Concentration on Long-Term Weight Change Among Virologically Suppressed People Living With HIV

Published:2021-06-01 Issue:2 Volume:87 Page:834-841
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Huang Sung-Hsi,Huang Wei-Chieh,Lin Shu-Wen,Chuang Yu-Chung,Sun Hsin-Yun,Chang Sui-Yuan,Kuo Po-Hsien,Wu Pei-Ying,Liu Wen-Chun,Chiang Chieh,Hung Chien-Ching,Chang Shan-Chwen

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference40 articles.

1. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies;Lancet.,2008

2. Life expectancy in HIV-positive persons in Switzerland;Gueler;AIDS.,2017

3. Achieving the fourth 90;Harris;AIDS.,2018

4. Adult obesity complications: challenges and clinical impact;Ansari;Ther Adv Endocrinol Metab.,2020

5. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation;Ferrante;J Intern Med.,2007

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prenatal efavirenz exposure is independently associated with maternal, but not fetal CYP2B6 genotype;Pharmacogenetics and Genomics;2024-06-24

2. Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studies;HIV Medicine;2024-05-17

3. Body weight and blood pressure changes on dolutegravir‐, efavirenz‐ or atazanavir‐based antiretroviral therapy in Zimbabwe: a longitudinal study;Journal of the International AIDS Society;2024-02

4. Rapid Initiation of Antiretroviral Therapy With Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide Versus Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate in HIV–Positive Men Who Have Sex With Men in China: Week 48 Results of the Multicenter, Randomized Clinical Trial;Clinical Infectious Diseases;2024-01-17

5. Weight and metabolic changes among virally suppressed people with HIV who switched to co-formulated bictegravir/emtricitabine/tenofovir alafenamide;Journal of Global Antimicrobial Resistance;2023-11